Brief: XOMA Royalty to acquire LAVA Therapeutics for $1.16-$1.24 per share

Xoma Royalty

04/08/2025 12:42

Aug 4 (Reuters) - LAVA Therapeutics NV LVTX.O:

XOMA ROYALTY ENTERS INTO AGREEMENT TO ACQUIRE LAVA THERAPEUTICS FOR BETWEEN $1.16 AND $1.24 PER SHARE IN CASH, PLUS A CONTINGENT VALUE RIGHT

XOMA ROYALTY CORP - ACQUISITION INCLUDES CVR FOR 75% OF NET PROCEEDS

XOMA ROYALTY CORP - TO COMMENCE TENDER OFFER TO ACQUIRE LAVA BY AUGUST 15, 2025

XOMA ROYALTY CORP - LAVA TO DISCONTINUE PHASE 1 TRIAL OF LAVA-1266

XOMA ROYALTY CORP: LAVA TO UNDERGO CORPORATE REORGANIZATION DESIGNED TO RESULT IN XOMA ROYALTY ACQUIRING 100% OF SHARES IN LAVA'S SUCCESSOR

XOMA ROYALTY CORP: LAVA TO INITIATE WIND-DOWN OF LAVA-1266 PROGRAM

Source text: ID:nGNXrrMyQ

Further company coverage: LVTX.O

 ((Reuters.Briefs@thomsonreuters.com;))